{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:17:21Z","timestamp":1772342241331,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.06.143","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T01:36:30Z","timestamp":1531359390000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways"],"prefix":"10.1016","volume":"106","author":[{"given":"Lingping","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anzhou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2018.06.143_bib0005","first-page":"381","article-title":"Nasopharyngeal carcinoma incidence and mortality in China in 2010","volume":"33","author":"Wei","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2018.06.143_bib0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5732\/cjc.013.10118","article-title":"Nasopharyngeal carcinoma incidence and mortality in China in 2009","volume":"32","author":"Xu","year":"2013","journal-title":"Chin. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2018.06.143_bib0015","first-page":"835","article-title":"Nasopharynx cancer epidemiology in China","volume":"25","author":"Xin","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2018.06.143_bib0020","article-title":"Nasopharynx cancer epidemiology in China","volume":"25","author":"LIANG","year":"2016","journal-title":"China Cancer"},{"key":"10.1016\/j.biopha.2018.06.143_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"Yu","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.biopha.2018.06.143_bib0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.biopha.2018.06.143_bib0035","first-page":"1587","article-title":"A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005","volume":"11","author":"Ren","year":"2010","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/annonc\/mdu507","article-title":"A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"26","author":"Chen","year":"2015","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2018.06.143_bib0045","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0360-3016(01)01537-1","article-title":"Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?","volume":"50","author":"Ma","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.biopha.2018.06.143_bib0050","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1039\/C5FO00374A","article-title":"Calycosin induces apoptosis by the regulation of ER\u03b2\/miR-17 signaling pathway in human colorectal cancer cells","volume":"6","author":"Chen","year":"2015","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.143_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000487031","article-title":"Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2018.06.143_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4251\/wjgo.v6.i8.289","article-title":"In-vitro effects of polyphenols on colo-rectal cancer cells","volume":"6","author":"Al","year":"2014","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.gene.2016.07.012","article-title":"Calycosin induces apoptosis in colorectal cancer cells, through modulating the ER\u03b2\/MiR-95 and IG Nasopharynx cancer F-1R, PI3K\/Akt signaling pathways","volume":"591","author":"Zhao","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2018.06.143_bib0070","first-page":"681","article-title":"Formononetin induces cell cycle arrest of human breast cancer cells via IGF1\/PI3K\/Akt pathways in vitro and in vivo","volume":"43","author":"Chen","year":"2011","journal-title":"Orig. Basic"},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yexmp.2014.04.014","article-title":"Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations","volume":"97","author":"Qiu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.143_bib0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1159\/000369732","article-title":"Calycosin and genistein induce apoptosis by inactivation of HOTAIR\/p-Akt signaling pathway in human breast cancer MCF-7 cells","volume":"35","author":"Chen","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-017-0625-y","article-title":"Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 signaling","volume":"36","author":"Tian","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2018.06.143_bib0090","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1172\/JCI72124","article-title":"Long noncoding RNA EWSAT1 -mediated gene repression facilitates Ewing sarcoma oncogenesis","volume":"124","author":"Howarth","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2018.06.143_bib0095","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/dna.2016.3467","article-title":"Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth and metastasis through suppression of MEG3 expression","volume":"35","author":"Sun","year":"2016","journal-title":"DNA Cell. Biol."},{"key":"10.1016\/j.biopha.2018.06.143_bib0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/his.12616","article-title":"Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray","author":"Yang","year":"2015","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.12302","article-title":"Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system","volume":"266","author":"Walsh","year":"2015","journal-title":"Immunol. Rev."},{"issue":"6599","key":"10.1016\/j.biopha.2018.06.143_bib0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/383443a0","article-title":"TRAF6 is a signal transducer for interleukin-1","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"issue":"46","key":"10.1016\/j.biopha.2018.06.143_bib0115","doi-asserted-by":"crossref","first-page":"28745","DOI":"10.1074\/jbc.271.46.28745","article-title":"Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region","volume":"271","author":"Ishida","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/dvdy.10400","article-title":"Traf6 Is essential for murine tooth cusp morphogenesis","volume":"229","author":"Ohazama","year":"2004","journal-title":"Dev. Dyn."},{"issue":"3","key":"10.1016\/j.biopha.2018.06.143_bib0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bjd.12018","article-title":"Functional studies for the TRAF6 mutation associated with hypohidrotic ectodermal dysplasia","volume":"168","author":"Fujikawa","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/dvdy.20110","article-title":"TRAF6-dependent NF-kB transcriptional activity during mouse development","volume":"231","author":"Dickson","year":"2004","journal-title":"Dev. Dyn."},{"issue":"5","key":"10.1016\/j.biopha.2018.06.143_bib0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biocel.2009.12.023","article-title":"The TAK1-TRAF6 signalling pathway","volume":"42","author":"Landstr\u00f6m","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2018.06.143_bib0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1349-7006.2007.00389.x","article-title":"NF-\u03baB activation in development and progression of cancer","volume":"98","author":"Inoue","year":"2007","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.biopha.2018.06.143_bib0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clml.2012.01.006","article-title":"TRAF6 activation in multiple myeloma: a potential therapeutic target","volume":"12","author":"Liu","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"10.1016\/j.biopha.2018.06.143_bib0150","first-page":"1","article-title":"Calycosin suppresses breast cancer cell growth via ER\u03b2-dependent regulation of IGF-1R, p38 MAPK and PI3K\/Akt pathways","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2018.06.143_bib0155","first-page":"4094","article-title":"LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression","volume":"9","author":"Fu","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.06.143_bib0160","first-page":"1","article-title":"Long non\u2010coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR\u2010326 \/\u2010330\u20105p","volume":"8","author":"Song","year":"2016","journal-title":"Aging (Albany N. Y.)"},{"key":"10.1016\/j.biopha.2018.06.143_bib0165","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs)","volume":"20","author":"Bradley","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2018.06.143_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-8-7","article-title":"TRAF molecules in cell signaling and in human diseases","volume":"8","author":"Xie","year":"2013","journal-title":"J. Mol. Signal."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.143_bib0175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.20071108","article-title":"Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20","volume":"205","author":"Turer","year":"2008","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.143_bib0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/cmi.2011.59","article-title":"Regulation of NF-[kgr]B signaling by the A20 deubiquitinase","volume":"9","author":"Shembade","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2018.06.143_bib0185","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ni1110","article-title":"The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses","volume":"5","author":"Boone","year":"2004","journal-title":"Nat. Immunol."},{"issue":"6844","key":"10.1016\/j.biopha.2018.06.143_bib0190","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"issue":"272","key":"10.1016\/j.biopha.2018.06.143_bib0195","article-title":"TAB1: an activator of the TAK1 MAPKKK in TGF-\u03b2 Signal transduction","volume":"80","author":"Shibuya","year":"1996","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.biopha.2018.06.143_bib0200","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","article-title":"Ubiquitin-mediated activation of TAK1 and IKK","volume":"26","author":"Adhikari","year":"2007","journal-title":"Oncogene"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218319735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218319735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:30:27Z","timestamp":1750879827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218319735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"alternative-id":["S0753332218319735"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.143","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}